Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

2.

Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?

Solomon DH, Schneeweiss S, Glynn RJ, Levin R, Avorn J.

Am J Med. 2003 Dec 15;115(9):715-20.

PMID:
14693324
4.
5.

Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.

Depont F, Fourrier A, Merlière Y, Droz C, Amouretti M, Bégaud B, Bénichou J, Moride Y, Velo GP, Sturkenboom M, Blin P, Moore N; CADEUS Team.

Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):891-900.

PMID:
17351983
6.

Evaluation of cyclooxygenase 2 inhibitor use in patients admitted to a large teaching hospital.

Landsberg PG, Pillans PI, Radford JM.

Intern Med J. 2003 May-Jun;33(5-6):225-8.

PMID:
12752891
7.
8.

Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.

Barozzi N, Tett SE.

Clin Ther. 2009 Apr;31(4):849-61. doi: 10.1016/j.clinthera.2009.04.012.

PMID:
19446158
9.
11.

A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.

Price-Forbes AN, Callaghan R, Allen ME, Rowe IF.

Rheumatology (Oxford). 2005 Jul;44(7):921-4. Epub 2005 Apr 12.

PMID:
15827035
12.

Prescriber adoption of newly approved selective COX-2 inhibitors.

Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AG.

Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1168-74. doi: 10.1002/pds.1667.

PMID:
18821717
13.

Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohort.

Shireman TI, Rigler SK.

Am J Geriatr Pharmacother. 2006 Sep;4(3):210-8.

PMID:
17062321
15.

Initiation of antihypertensive therapy among new users of cyclooxygenase-2-selective and nonselective NSAIDs.

Langman MJ, Eichler HG, Mavros P, Watson DJ, Kong SX.

Int J Clin Pharmacol Ther. 2004 May;42(5):260-6.

PMID:
15176648
17.

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.

Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S.

Arthritis Res Ther. 2005;7(2):R333-42. Epub 2005 Jan 17.

18.
19.

Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis.

Ofman JJ, Badamgarav E, Henning JM, Knight K, Laine L.

Am J Med. 2004 Jun 15;116(12):835-42.

PMID:
15178499
20.

Nonsteroidal antiinflammatory drug use among patients with GI bleeding.

Dominick KL, Bosworth HB, Jeffreys AS, Grambow SC, Oddone EZ, Horner RD.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1159-64. Epub 2004 Jun 8.

PMID:
15187205

Supplemental Content

Support Center